SAREPTA THERAPEUTICS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
SAREPTA THERAPEUTICS, INC. (SRPT) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $213.00 thousand as of 2018-09-30, per its 10-Q filed 2018-10-31.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2018-10-31
- 2018-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $213.00K.
- 2018-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $5.00K.
- 2018-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $1.00K.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $2.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2018-09-30 | $213.00K 10-Q · filed 2018-10-31 |
| 2018-06-30 | $5.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $2.00K 10-Q · filed 2018-10-31 |
| 2016-06-30 | $1.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $3.00K 10-Q · filed 2016-05-05 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |